List of Tables
Table 1. Global Pertussis Vaccine Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Table 2. Major Manufacturers of Whole-cell Vaccines
Table 3. Major Manufacturers of Acellular Vaccines
Table 4. Global Pertussis Vaccine Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Table 5. Global Pertussis Vaccine Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 6. Global Pertussis Vaccine Revenue by Region (2019-2024) & (US$ Million)
Table 7. Global Pertussis Vaccine Revenue by Region (2025-2030) & (US$ Million)
Table 8. Global Pertussis Vaccine Revenue Market Share by Region (2019-2024)
Table 9. Global Pertussis Vaccine Revenue Market Share by Region (2025-2030)
Table 10. Global Pertussis Vaccine Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 11. Global Pertussis Vaccine Sales by Region (2019-2024) & (M Doses)
Table 12. Global Pertussis Vaccine Sales by Region (2025-2030) & (M Doses)
Table 13. Global Pertussis Vaccine Sales Market Share by Region (2019-2024)
Table 14. Global Pertussis Vaccine Sales Market Share by Region (2025-2030)
Table 15. Global Pertussis Vaccine Sales by Manufacturers (2019-2024) & (M Doses)
Table 16. Global Pertussis Vaccine Sales Share by Manufacturers (2019-2024)
Table 17. Global Pertussis Vaccine Revenue by Manufacturers (2019-2024) & (US$ Million)
Table 18. Global Pertussis Vaccine Revenue Share by Manufacturers (2019-2024)
Table 19. Global Key Players of Pertussis Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
Table 20. Pertussis Vaccine Price by Manufacturers 2019-2024 (USD/Doses)
Table 21. Global Pertussis Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Pertussis Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pertussis Vaccine as of 2023)
Table 23. Global Key Manufacturers of Pertussis Vaccine, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Pertussis Vaccine, Product Offered and Application
Table 25. Global Key Manufacturers of Pertussis Vaccine, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Pertussis Vaccine Sales by Type (2019-2024) & (M Doses)
Table 28. Global Pertussis Vaccine Sales by Type (2025-2030) & (M Doses)
Table 29. Global Pertussis Vaccine Sales Share by Type (2019-2024)
Table 30. Global Pertussis Vaccine Sales Share by Type (2025-2030)
Table 31. Global Pertussis Vaccine Revenue by Type (2019-2024) & (US$ Million)
Table 32. Global Pertussis Vaccine Revenue by Type (2025-2030) & (US$ Million)
Table 33. Global Pertussis Vaccine Revenue Share by Type (2019-2024)
Table 34. Global Pertussis Vaccine Revenue Share by Type (2025-2030)
Table 35. Pertussis Vaccine Price by Type (2019-2024) & (USD/Doses)
Table 36. Global Pertussis Vaccine Price Forecast by Type (2025-2030) & (USD/Doses)
Table 37. Global Pertussis Vaccine Sales by Application (2019-2024) & (M Doses)
Table 38. Global Pertussis Vaccine Sales by Application (2025-2030) & (M Doses)
Table 39. Global Pertussis Vaccine Sales Share by Application (2019-2024)
Table 40. Global Pertussis Vaccine Sales Share by Application (2025-2030)
Table 41. Global Pertussis Vaccine Revenue by Application (2019-2024) & (US$ Million)
Table 42. Global Pertussis Vaccine Revenue by Application (2025-2030) & (US$ Million)
Table 43. Global Pertussis Vaccine Revenue Share by Application (2019-2024)
Table 44. Global Pertussis Vaccine Revenue Share by Application (2025-2030)
Table 45. Pertussis Vaccine Price by Application (2019-2024) & (USD/Doses)
Table 46. Global Pertussis Vaccine Price Forecast by Application (2025-2030) & (USD/Doses)
Table 47. US & Canada Pertussis Vaccine Sales by Type (2019-2024) & (M Doses)
Table 48. US & Canada Pertussis Vaccine Sales by Type (2025-2030) & (M Doses)
Table 49. US & Canada Pertussis Vaccine Revenue by Type (2019-2024) & (US$ Million)
Table 50. US & Canada Pertussis Vaccine Revenue by Type (2025-2030) & (US$ Million)
Table 51. US & Canada Pertussis Vaccine Sales by Application (2019-2024) & (M Doses)
Table 52. US & Canada Pertussis Vaccine Sales by Application (2025-2030) & (M Doses)
Table 53. US & Canada Pertussis Vaccine Revenue by Application (2019-2024) & (US$ Million)
Table 54. US & Canada Pertussis Vaccine Revenue by Application (2025-2030) & (US$ Million)
Table 55. US & Canada Pertussis Vaccine Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 56. US & Canada Pertussis Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 57. US & Canada Pertussis Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 58. US & Canada Pertussis Vaccine Sales by Country (2019-2024) & (M Doses)
Table 59. US & Canada Pertussis Vaccine Sales by Country (2025-2030) & (M Doses)
Table 60. Europe Pertussis Vaccine Sales by Type (2019-2024) & (M Doses)
Table 61. Europe Pertussis Vaccine Sales by Type (2025-2030) & (M Doses)
Table 62. Europe Pertussis Vaccine Revenue by Type (2019-2024) & (US$ Million)
Table 63. Europe Pertussis Vaccine Revenue by Type (2025-2030) & (US$ Million)
Table 64. Europe Pertussis Vaccine Sales by Application (2019-2024) & (M Doses)
Table 65. Europe Pertussis Vaccine Sales by Application (2025-2030) & (M Doses)
Table 66. Europe Pertussis Vaccine Revenue by Application (2019-2024) & (US$ Million)
Table 67. Europe Pertussis Vaccine Revenue by Application (2025-2030) & (US$ Million)
Table 68. Europe Pertussis Vaccine Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 69. Europe Pertussis Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 70. Europe Pertussis Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 71. Europe Pertussis Vaccine Sales by Country (2019-2024) & (M Doses)
Table 72. Europe Pertussis Vaccine Sales by Country (2025-2030) & (M Doses)
Table 73. China Pertussis Vaccine Sales by Type (2019-2024) & (M Doses)
Table 74. China Pertussis Vaccine Sales by Type (2025-2030) & (M Doses)
Table 75. China Pertussis Vaccine Revenue by Type (2019-2024) & (US$ Million)
Table 76. China Pertussis Vaccine Revenue by Type (2025-2030) & (US$ Million)
Table 77. China Pertussis Vaccine Sales by Application (2019-2024) & (M Doses)
Table 78. China Pertussis Vaccine Sales by Application (2025-2030) & (M Doses)
Table 79. China Pertussis Vaccine Revenue by Application (2019-2024) & (US$ Million)
Table 80. China Pertussis Vaccine Revenue by Application (2025-2030) & (US$ Million)
Table 81. Asia Pertussis Vaccine Sales by Type (2019-2024) & (M Doses)
Table 82. Asia Pertussis Vaccine Sales by Type (2025-2030) & (M Doses)
Table 83. Asia Pertussis Vaccine Revenue by Type (2019-2024) & (US$ Million)
Table 84. Asia Pertussis Vaccine Revenue by Type (2025-2030) & (US$ Million)
Table 85. Asia Pertussis Vaccine Sales by Application (2019-2024) & (M Doses)
Table 86. Asia Pertussis Vaccine Sales by Application (2025-2030) & (M Doses)
Table 87. Asia Pertussis Vaccine Revenue by Application (2019-2024) & (US$ Million)
Table 88. Asia Pertussis Vaccine Revenue by Application (2025-2030) & (US$ Million)
Table 89. Asia Pertussis Vaccine Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 90. Asia Pertussis Vaccine Revenue by Region (2019-2024) & (US$ Million)
Table 91. Asia Pertussis Vaccine Revenue by Region (2025-2030) & (US$ Million)
Table 92. Asia Pertussis Vaccine Sales by Region (2019-2024) & (M Doses)
Table 93. Asia Pertussis Vaccine Sales by Region (2025-2030) & (M Doses)
Table 94. Middle East, Africa and Latin America Pertussis Vaccine Sales by Type (2019-2024) & (M Doses)
Table 95. Middle East, Africa and Latin America Pertussis Vaccine Sales by Type (2025-2030) & (M Doses)
Table 96. Middle East, Africa and Latin America Pertussis Vaccine Revenue by Type (2019-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Pertussis Vaccine Revenue by Type (2025-2030) & (US$ Million)
Table 98. Middle East, Africa and Latin America Pertussis Vaccine Sales by Application (2019-2024) & (M Doses)
Table 99. Middle East, Africa and Latin America Pertussis Vaccine Sales by Application (2025-2030) & (M Doses)
Table 100. Middle East, Africa and Latin America Pertussis Vaccine Revenue by Application (2019-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Pertussis Vaccine Revenue by Application (2025-2030) & (US$ Million)
Table 102. Middle East, Africa and Latin America Pertussis Vaccine Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 103. Middle East, Africa and Latin America Pertussis Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Pertussis Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 105. Middle East, Africa and Latin America Pertussis Vaccine Sales by Country (2019-2024) & (M Doses)
Table 106. Middle East, Africa and Latin America Pertussis Vaccine Sales by Country (2025-2030) & (M Doses)
Table 107. Sanofi Pasteur Company Information
Table 108. Sanofi Pasteur Description and Major Businesses
Table 109. Sanofi Pasteur Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 110. Sanofi Pasteur Pertussis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Sanofi Pasteur Recent Developments
Table 112. GSK Company Information
Table 113. GSK Description and Major Businesses
Table 114. GSK Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 115. GSK Pertussis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. GSK Recent Developments
Table 117. Mitsubishi Tanabe Pharma Company Information
Table 118. Mitsubishi Tanabe Pharma Description and Major Businesses
Table 119. Mitsubishi Tanabe Pharma Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 120. Mitsubishi Tanabe Pharma Pertussis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Mitsubishi Tanabe Pharma Recent Developments
Table 122. Wuhan Institute of Biological Products Company Information
Table 123. Wuhan Institute of Biological Products Description and Major Businesses
Table 124. Wuhan Institute of Biological Products Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 125. Wuhan Institute of Biological Products Pertussis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Wuhan Institute of Biological Products Recent Developments
Table 127. Walvax Biotechnology Company Information
Table 128. Walvax Biotechnology Description and Major Businesses
Table 129. Walvax Biotechnology Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 130. Walvax Biotechnology Pertussis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Walvax Biotechnology Recent Developments
Table 132. Minhai Biotechnology Company Information
Table 133. Minhai Biotechnology Description and Major Businesses
Table 134. Minhai Biotechnology Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 135. Minhai Biotechnology Pertussis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Minhai Biotechnology Recent Developments
Table 137. KM Biologics Company Information
Table 138. KM Biologics Description and Major Businesses
Table 139. KM Biologics Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 140. KM Biologics Pertussis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. KM Biologics Recent Developments
Table 142. Chengdu Institute of Biological Products Company Information
Table 143. Chengdu Institute of Biological Products Description and Major Businesses
Table 144. Chengdu Institute of Biological Products Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 145. Chengdu Institute of Biological Products Pertussis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Chengdu Institute of Biological Products Recent Developments
Table 147. Key Raw Materials Lists
Table 148. Raw Materials Key Suppliers Lists
Table 149. Pertussis Vaccine Distributors List
Table 150. Pertussis Vaccine Customers List
Table 151. Pertussis Vaccine Market Trends
Table 152. Pertussis Vaccine Market Drivers
Table 153. Pertussis Vaccine Market Challenges
Table 154. Pertussis Vaccine Market Restraints
Table 155. Research Programs/Design for This Report
Table 156. Key Data Information from Secondary Sources
Table 157. Key Data Information from Primary Sources
List of Figures
Figure 1. Pertussis Vaccine Product Picture
Figure 2. Global Pertussis Vaccine Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Pertussis Vaccine Market Share by Type in 2023 & 2030
Figure 4. Whole-cell Vaccines Product Picture
Figure 5. Acellular Vaccines Product Picture
Figure 6. Global Pertussis Vaccine Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 7. Global Pertussis Vaccine Market Share by Application in 2023 & 2030
Figure 8. 12 Months Below
Figure 9. 12 Months Above
Figure 10. Pertussis Vaccine Report Years Considered
Figure 11. Global Pertussis Vaccine Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Pertussis Vaccine Revenue 2019-2030 (US$ Million)
Figure 13. Global Pertussis Vaccine Revenue Market Share by Region in Percentage: 2023 Versus 2030
Figure 14. Global Pertussis Vaccine Revenue Market Share by Region (2019-2030)
Figure 15. Global Pertussis Vaccine Sales 2019-2030 ((M Doses)
Figure 16. Global Pertussis Vaccine Sales Market Share by Region (2019-2030)
Figure 17. US & Canada Pertussis Vaccine Sales YoY (2019-2030) & (M Doses)
Figure 18. US & Canada Pertussis Vaccine Revenue YoY (2019-2030) & (US$ Million)
Figure 19. Europe Pertussis Vaccine Sales YoY (2019-2030) & (M Doses)
Figure 20. Europe Pertussis Vaccine Revenue YoY (2019-2030) & (US$ Million)
Figure 21. China Pertussis Vaccine Sales YoY (2019-2030) & (M Doses)
Figure 22. China Pertussis Vaccine Revenue YoY (2019-2030) & (US$ Million)
Figure 23. Asia (excluding China) Pertussis Vaccine Sales YoY (2019-2030) & (M Doses)
Figure 24. Asia (excluding China) Pertussis Vaccine Revenue YoY (2019-2030) & (US$ Million)
Figure 25. Middle East, Africa and Latin America Pertussis Vaccine Sales YoY (2019-2030) & (M Doses)
Figure 26. Middle East, Africa and Latin America Pertussis Vaccine Revenue YoY (2019-2030) & (US$ Million)
Figure 27. The Pertussis Vaccine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
Figure 28. The Top 5 and 10 Largest Manufacturers of Pertussis Vaccine in the World: Market Share by Pertussis Vaccine Revenue in 2023
Figure 29. Global Pertussis Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 30. Global Pertussis Vaccine Sales Market Share by Type (2019-2030)
Figure 31. Global Pertussis Vaccine Revenue Market Share by Type (2019-2030)
Figure 32. Global Pertussis Vaccine Sales Market Share by Application (2019-2030)
Figure 33. Global Pertussis Vaccine Revenue Market Share by Application (2019-2030)
Figure 34. US & Canada Pertussis Vaccine Sales Market Share by Type (2019-2030)
Figure 35. US & Canada Pertussis Vaccine Revenue Market Share by Type (2019-2030)
Figure 36. US & Canada Pertussis Vaccine Sales Market Share by Application (2019-2030)
Figure 37. US & Canada Pertussis Vaccine Revenue Market Share by Application (2019-2030)
Figure 38. US & Canada Pertussis Vaccine Revenue Share by Country (2019-2030)
Figure 39. US & Canada Pertussis Vaccine Sales Share by Country (2019-2030)
Figure 40. U.S. Pertussis Vaccine Revenue (2019-2030) & (US$ Million)
Figure 41. Canada Pertussis Vaccine Revenue (2019-2030) & (US$ Million)
Figure 42. Europe Pertussis Vaccine Sales Market Share by Type (2019-2030)
Figure 43. Europe Pertussis Vaccine Revenue Market Share by Type (2019-2030)
Figure 44. Europe Pertussis Vaccine Sales Market Share by Application (2019-2030)
Figure 45. Europe Pertussis Vaccine Revenue Market Share by Application (2019-2030)
Figure 46. Europe Pertussis Vaccine Revenue Share by Country (2019-2030)
Figure 47. Europe Pertussis Vaccine Sales Share by Country (2019-2030)
Figure 48. Germany Pertussis Vaccine Revenue (2019-2030) & (US$ Million)
Figure 49. France Pertussis Vaccine Revenue (2019-2030) & (US$ Million)
Figure 50. U.K. Pertussis Vaccine Revenue (2019-2030) & (US$ Million)
Figure 51. Italy Pertussis Vaccine Revenue (2019-2030) & (US$ Million)
Figure 52. Russia Pertussis Vaccine Revenue (2019-2030) & (US$ Million)
Figure 53. China Pertussis Vaccine Sales Market Share by Type (2019-2030)
Figure 54. China Pertussis Vaccine Revenue Market Share by Type (2019-2030)
Figure 55. China Pertussis Vaccine Sales Market Share by Application (2019-2030)
Figure 56. China Pertussis Vaccine Revenue Market Share by Application (2019-2030)
Figure 57. Asia Pertussis Vaccine Sales Market Share by Type (2019-2030)
Figure 58. Asia Pertussis Vaccine Revenue Market Share by Type (2019-2030)
Figure 59. Asia Pertussis Vaccine Sales Market Share by Application (2019-2030)
Figure 60. Asia Pertussis Vaccine Revenue Market Share by Application (2019-2030)
Figure 61. Asia Pertussis Vaccine Revenue Share by Region (2019-2030)
Figure 62. Asia Pertussis Vaccine Sales Share by Region (2019-2030)
Figure 63. Japan Pertussis Vaccine Revenue (2019-2030) & (US$ Million)
Figure 64. South Korea Pertussis Vaccine Revenue (2019-2030) & (US$ Million)
Figure 65. China Taiwan Pertussis Vaccine Revenue (2019-2030) & (US$ Million)
Figure 66. Southeast Asia Pertussis Vaccine Revenue (2019-2030) & (US$ Million)
Figure 67. India Pertussis Vaccine Revenue (2019-2030) & (US$ Million)
Figure 68. Middle East, Africa and Latin America Pertussis Vaccine Sales Market Share by Type (2019-2030)
Figure 69. Middle East, Africa and Latin America Pertussis Vaccine Revenue Market Share by Type (2019-2030)
Figure 70. Middle East, Africa and Latin America Pertussis Vaccine Sales Market Share by Application (2019-2030)
Figure 71. Middle East, Africa and Latin America Pertussis Vaccine Revenue Market Share by Application (2019-2030)
Figure 72. Middle East, Africa and Latin America Pertussis Vaccine Revenue Share by Country (2019-2030)
Figure 73. Middle East, Africa and Latin America Pertussis Vaccine Sales Share by Country (2019-2030)
Figure 74. Brazil Pertussis Vaccine Revenue (2019-2030) & (US$ Million)
Figure 75. Mexico Pertussis Vaccine Revenue (2019-2030) & (US$ Million)
Figure 76. Turkey Pertussis Vaccine Revenue (2019-2030) & (US$ Million)
Figure 77. Israel Pertussis Vaccine Revenue (2019-2030) & (US$ Million)
Figure 78. GCC Countries Pertussis Vaccine Revenue (2019-2030) & (US$ Million)
Figure 79. Pertussis Vaccine Value Chain
Figure 80. Pertussis Vaccine Production Process
Figure 81. Channels of Distribution
Figure 82. Distributors Profiles
Figure 83. Bottom-up and Top-down Approaches for This Report
Figure 84. Data Triangulation
Figure 85. Key Executives Interviewed